Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer
NCT00125359
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Carcinoma, Non-small-cell Lung
Interventions
DRUG:
erlotinib and bexarotene
Sponsor
Konstantin Dragnev
Collaborators
[object Object]
[object Object]